Results from the phase 3 AMPLIFY trial are intended to support an application to the FDA for potential approval of 64Cu-SAR-bisPSMA. The first clinical trial site has been initiated in the pivotal ...

Genomic alteration frequencies differ between non-Hispanic Black and non-Hispanic White veterans with metastatic prostate cancer, but survival outcomes are similar. Non-Hispanic Black patients have ...

Cytoreductive nephrectomy (CN) remains vital in mRCC management, with immune checkpoint inhibitors (ICI) reshaping treatment strategies and patient selection criteria. The SCREEN score offers superior ...

"There was a significant increase in overall fatigue after performing flexible ureteroscopy," says Sarah Razavi, MD. “This was a multi-institutional study, and the goal was to evaluate the urologist ...

Dr Shore presented data demonstrating that patients achieving ultra-low PSA levels (<0.02 ng/mL) experienced improved clinical outcomes. The analysis showed correlations between ultra-low PSA and ...

Black men are significantly underrepresented in prostate cancer clinical trials (<5% in most studies). Many trials fail to provide race-specific data. The ARANOTE study achieved 10% representation of ...

Research highlights the significant benefits of achieving ultra-low PSA levels in metastatic hormone-sensitive prostate cancer, delaying disease progression effectively. Dr Shore explained the ...

CT scans remain the most common initial imaging modality for renal mass detection. MRI offers additional sequencing capabilities for better tumor characterization. Ultrasound primarily helps determine ...

Current 2025 guidelines recommend ADT with intensification. Multiple intensification options include abiraterone, darolutamide, and docetaxel. Key clinical trials include ARANOTE, ARASENS, and TITAN.

Masses under 2 cm are typically managed with active surveillance. Options for masses that are 2 to 4 cm include ablation (eg, cryotherapy, radiofrequency ablation) and surgical approaches. Kidney ...

In this episode of Pearls & Perspectives, host Amy Pearlman, MD, sits down with Alex Tatem, MD, a urologist with Urology of Indiana and corporate director of men’s health for US Urology Partners, for ...

The first successful human bladder transplant was performed by USC and UCLA surgeons, marking a significant medical milestone. The patient, previously on dialysis, showed immediate improvement ...